J.P. Morgan Asset Management Launches Two Active ETFs: JTEK and JDOC
- J.P. Morgan Asset Management is a top ten ETF issuer in the U.S.
- JTEK invests in technology and technology-enabled companies.
- JDOC invests in pharmaceutical, biotechnology, healthcare services, healthcare technology, medical technology, and life sciences companies.
- Both funds aim to provide long-term capital appreciation.
- JTEK employs a flexible, all-cap approach to investing.
- JDOC is managed by a team with over 10 years of an established track record.
- None.
Funds seek to deliver JPM active management expertise and risk controls through ETF technology
JPMorgan
The strategy is run by managing director Joseph Wilson and executive director Eric Ghernati who also currently serve as co-portfolio managers of the J.P. Morgan
JPMorgan Healthcare Leaders ETF (JDOC) seeks to provide long-term capital appreciation by primarily investing in equity securities issued by pharmaceutical, biotechnology, healthcare services, healthcare technology, medical technology and life sciences companies. Leveraging an existing healthcare strategy with a strong performance track record, J.P. Morgan Asset Management has created JDOC to provide a differentiated solution that can be broadly accessed by our clients. JDOC was listed on the Nasdaq Stock Exchange on November 2, 2023.
The strategy is led by a proven team of managing director Matt Cohen, M.D., managing director Holly Morris, and executive director Dominic Valder, with over 10 years of an established track record.
"Technology and healthcare play a vital role in investor portfolios," said Bryon Lake, Global Head of ETF Solutions at J.P. Morgan Asset Management. "We're excited to offer our clients these attractive new strategies that can help them achieve the right balance of active security selection, while maintaining thoughtful portfolio construction and risk management."
J.P. Morgan Asset Management ranks as a top ten ETF issuer in the
Both funds will be priced at 65 basis points.
About J.P. Morgan Asset Management
J.P. Morgan Asset Management, with assets under management of
JPMorgan Chase & Co. (NYSE: JPM) is a leading financial services firm based in the
Investors should carefully consider the investment objectives and risks as well as charges and expenses of an ETF before investing. The summary and full prospectuses contain this and other information about the ETF and should be read carefully before investing. To obtain a prospectus: Call 1-844-4JPM-ETF.
Risk Summary, JTEK: Investments that are concentrated in a single industry, region, or issuer do not represent a complete investment program and may lead to a higher degree of market risk.
Risk Summary, JDOC: Companies in the healthcare sector are subject to extensive government regulation and their profitability can be significantly affected by restrictions on government reimbursement for medical expenses, rising costs of medical products and services, pricing pressure, limited product lines and an increased emphasis on the delivery of healthcare through outpatient services. Companies in the healthcare sector are heavily dependent on obtaining and defending patents, which may be time consuming and costly. The expiration of patents may adversely affect the profitability of these companies. Healthcare companies are also subject to extensive litigation based on product liability and similar claims. In addition, their products can become obsolete due to industry innovation and changes in technologies. Developments affecting the healthcare sector and industries within this sector may have a disproportionate impact on this investment.
J.P. Morgan Distribution Services, Inc., member FINRA
NOT FDIC INSURED | NO BANK GUARANTEE | MAY LOSE VALUE
1 Data according to Bloomberg as of October 24, 2023.
View original content to download multimedia:https://www.prnewswire.com/news-releases/jp-morgan-asset-management-launches-two-active-etfs-jtek-and-jdoc-301975773.html
SOURCE J.P. Morgan Asset Management
